Prostate Specific Membrane Antigen and integrin αvβ3, are biomarkers that are overexpressed on the cell surface of certain tumor epithelium as well as most solid tumor neovasculature and are critical targets for cancer therapy. This evidence concerns the gene FOLH1 and cancer.